Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib

Inflamm Bowel Dis. 2020 Jun 18;26(7):e64. doi: 10.1093/ibd/izaa093.

Authors

Jeffrey Jacobs¹, Kindra Clark-Snustad¹, Scott Lee¹

Affiliation

¹ University of Washington School of Medicine, Department of Medicine, Division of Gastroenterology, Seattle, Washington, USA.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Betacoronavirus / isolation & purification
COVID-19
Colitis, Ulcerative* / diagnosis
Colitis, Ulcerative* / drug therapy
Colitis, Ulcerative* / epidemiology
Colitis, Ulcerative* / physiopathology
Colonoscopy / methods
Comorbidity
Coronavirus Infections* / diagnosis
Coronavirus Infections* / epidemiology
Coronavirus Infections* / physiopathology
Female
Humans
Medication Therapy Management*
Pandemics*
Patient Acuity
Piperidines* / administration & dosage
Piperidines* / adverse effects
Pneumonia, Viral* / diagnosis
Pneumonia, Viral* / epidemiology
Pneumonia, Viral* / physiopathology
Protein Kinase Inhibitors / administration & dosage
Protein Kinase Inhibitors / adverse effects
Pyrimidines* / administration & dosage
Pyrimidines* / adverse effects
Pyrroles* / administration & dosage
Pyrroles* / adverse effects
SARS-CoV-2
Symptom Assessment
Treatment Outcome

Substances

Piperidines
Protein Kinase Inhibitors
Pyrimidines
Pyrroles
tofacitinib